UPDATE ON ICOSAPENT ETHYL IN STATIN USING PATIENTS SUFFERING FROM T2DM

Dear my friends and fellow Colleagues, Here us an update on Icosapent. Icosapent ethyl 4 g/day provides robust CV benefits in statin treated patients with DM. It has shown large relative and absolute risk reductions in both first and total CV events. Reference Diabetes 2020 Jun; 69 (Supplement 1) Regards and thanks, Dr Sepuri Krishna Mohan.

5 Likes

LikeAnswersShare

Sir in which form it is available.

Very valid question. Icosapent is a type of 3 Omega fatty Acids which is available in Fish Fish oils
2

View 6 other replies

New to learn Nice update sir

Valuable opinion
0

Thanks

I agree
0